Page last updated: 2024-09-02

tanshinone and Atheroma

tanshinone has been researched along with Atheroma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Cui, Y; Du, X; Gao, M; Hou, Y; Li, Z; Tian, Z; Wang, J; Xu, J1
Gao, F; Jia, W; Li, C; Ma, X; Zhang, L1
Li, H; Tong, L; Wan, Y; Zhang, L; Zhang, T; Zhao, D1
Gu, X; Liu, JP; Lu, H; Wu, ZM; Xiao, Y; Xu, YM; Zhang, WL1
Li, J; Liu, J; Wang, J; Wu, Z; Xu, Y; Zhang, W1

Other Studies

5 other study(ies) available for tanshinone and Atheroma

ArticleYear
Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis.
    Journal of ethnopharmacology, 2023, Dec-05, Volume: 317

    Topics: Animals; Atherosclerosis; Hypoxia; Interleukin-1beta; Mice; Molecular Docking Simulation; Plaque, Atherosclerotic; Succinates; Succinic Acid

2023
Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 167

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Cyclooxygenase 2; Inflammation; Mice; Molecular Docking Simulation; NF-kappa B; Plaque, Atherosclerotic; Salvia miltiorrhiza

2023
Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice.
    Molecular medicine reports, 2016, Volume: 14, Issue:6

    Topics: Abietanes; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Biopsy; Disease Models, Animal; Immunohistochemistry; Inflammation Mediators; Male; MAP Kinase Signaling System; Matrix Metalloproteinases; Mice; Mice, Knockout; NF-kappa B; Plaque, Atherosclerotic; Receptor for Advanced Glycation End Products; Signal Transduction

2016
Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.
    International journal of pharmaceutics, 2011, Oct-31, Volume: 419, Issue:1-2

    Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cholesterol Esters; Drug Carriers; Drug Delivery Systems; Guanidine; Lipoproteins; Lipoproteins, HDL; Macrophages; Mice; Models, Biological; Nanoparticles; Phagocytosis; Plaque, Atherosclerotic; Triolein

2011
Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
    Die Pharmazie, 2012, Volume: 67, Issue:4

    Topics: Abietanes; Animals; Apolipoproteins; Cardiovascular Agents; Cell Line; Circular Dichroism; Drug Carriers; Drug Delivery Systems; Electrochemistry; Foam Cells; In Vitro Techniques; Infusions, Parenteral; Lipoproteins, HDL; Liposomes; Male; Mice; Models, Biological; Nanoparticles; Particle Size; Phagocytosis; Plaque, Atherosclerotic; Plasmids; Rabbits; Reproducibility of Results; Transfection

2012